Pharmaco-economic evaluations: Cost-Effectiveness analysis, Cost-Utility analysis, Cost-Benefit analysis
Budget Impact and Cost of Illness Analysis from the National Health Service Perspective
Study, development and validation of useful tools for clinical trials such as Patients Reported Outcomes
Epidemiological analyses from clinical and administrative databases
Therapeutic areas of expertise: rare diseases, cardiometabolic diseases, cardiovascular diseases, infectious diseases, respiratory diseases, oncological diseases
